pantoprazole has been researched along with Cancer of Colon in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pantoprazole can alleviate cancer cachexia-induced body weight reduction and inhibit skeletal muscle wasting in a dose-dependent manner." | 7.85 | Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response. ( Guo, D; Qiao, Z; Tang, H; Wang, C; Wang, Q, 2017) |
| "Pantoprazole can alleviate cancer cachexia-induced body weight reduction and inhibit skeletal muscle wasting in a dose-dependent manner." | 3.85 | Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response. ( Guo, D; Qiao, Z; Tang, H; Wang, C; Wang, Q, 2017) |
| "Though long-term administration of proton pump inhibitor (PPI) imposed the risk of gastrointestinal track tumorigenesis by accompanied hypergastrinemia, no overt increases of colon cancer risk were witnessed after a long-term cohort study." | 1.40 | Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model. ( Hahm, KB; Han, YM; Hong, SP; Kim, EH; Park, JM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, D | 1 |
| Wang, C | 1 |
| Wang, Q | 1 |
| Qiao, Z | 1 |
| Tang, H | 1 |
| Han, YM | 1 |
| Hahm, KB | 1 |
| Park, JM | 1 |
| Hong, SP | 1 |
| Kim, EH | 1 |
2 other studies available for pantoprazole and Cancer of Colon
| Article | Year |
|---|---|
Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Apoptosis; Cachexia; Cell Prolifer | 2017 |
Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Active Transport, Cell Nucleus; Animals; Antineoplastic Age | 2014 |